What BrightHeart Announced About the Voluson Solution Store
BrightHeart said on 6 February 2026 that its B-Right AI platform is available through GE HealthCare's Voluson Solution Store. The company says the collaboration is meant to improve early detection of congenital defects and reduce uncertainty in reading a prenatal scan. It repeats that B-Right Views and B-Right Screen are each Class II FDA cleared and Class IIa CE marked under notified body 3022.
Why the BrightHeart and GE HealthCare Collaboration Matters to Ultrasound Buyers
A scanner maker's own store is the cheapest way for a small vendor to reach the people already using that machine, and the Voluson line is widely used in obstetric ultrasound. It also makes the software easier to buy than to compare, so a department should still ask for the evidence rather than treating a listing as a recommendation. GE HealthCare distributing a product is not GE HealthCare validating it, and the clearances remain BrightHeart's.
Where the BrightHeart Update Comes From
BrightHeart is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
How We Would Research the BrightHeart Voluson Collaboration
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would start by confirming with GE HealthCare which Voluson models and software versions the platform runs on.
- Then we would ask BrightHeart what the store listing covers commercially, since a storefront is not the same as a support agreement.
- We would ask both companies who is responsible when the AI and the sonographer disagree during a live exam.